Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review
- 430 Downloads
Nerve growth factor (NGF) is a signalling protein that interacts with specific receptors in autocrine, paracrine and endocrine modes. It is produced by bladder smooth muscle and urothelium. Patients with overactive bladder and detrusor overactivity (DO) have been found to have increased urinary NGF levels in several small studies. The objective of the review was to assess the accuracy of NGF as a biomarker in the diagnosis of DO by a systematic review of the literature. A systematic search of MEDLINE, Embase, CINAHL, MEDION and LILACS databases was conducted (inception till December 2012). Selection criteria included studies where NGF (as a biomarker for DO) and urodynamics were performed in humans with symptoms of overactive bladder. Two reviewers independently selected articles and extracted data on study characteristics, quality and results. All the eight included studies were of case-control design. A meta-analysis was not performed as there were variations in the quality, methods of performing the NGF assay, different NGF cut-offs used and the format of reporting findings. Two studies used a cut-off of 0.05 for NGF levels. Six studies observed a trend towards higher NGF levels in patients with DO. There was a trend towards higher NGF in patients with DO. However, the data are imprecise and hence cannot be recommended for use in current clinical practice.
KeywordsDetrusor overactivity Overactive bladder Urodynamics Nerve growth factor
Nerve growth factor
United Kingdom Continence Society
International Continence Society
International Urogynecological Association
Quality assessment of diagnostic accuracy studies
Preferred reporting items for systematic reviews and meta-analyses
We thank Mr. Derick Yates, librarian at the Birmingham Women’s Hospital for helping with the literature search. SR is the clinical Research Fellow for the BUS study which is funded by NIHR HTA programme. PL is the CI on this study.
Conflicts of interest
- 6.Foon R, Toozs-Hobson P, Latthe P (2012) Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies. Cochrane Database Syst Rev 10:CD008224Google Scholar
- 14.Vijaya G, Gallo P, Derpapas A, Cartwright R, Digesu G, Dell’utri C et al (2011) Increased nerve growth factor in overactive bladder: is it caused by infection? Int Urogynecol J 22:S187–S188 (Conference abstract)Google Scholar
- 23.Vijaya G, Cartwright R, Digesu G et al (2011) Can urinary nerve growth factor (NGF) replace urodynamics to diagnose lower urinary tract symptoms? Int Urogynecol J 22:S20–S21 (Conference abstract)Google Scholar
- 25.Seth J, Sahai A, Oppenheim M, Dasgupta P, Panicker J, Fowler C (2012) Urinary nerve growth factor in neurogenic bladder dysfunction. J Endourol 26(A/23):887–892Google Scholar